NRBF2 regulates the chemoresistance of small cell lung cancer by interacting with the P62 protein in the autophagy process

Reversing chemotherapy resistance in small cell lung cancer (SCLC) is crucial to improve patient prognosis. The present study aims to investigate the underlying mechanisms in SCLC chemoresistance. We see that nuclear receptor binding factor 2 (NRBF2) is a poor prognostic factor in SCLC. The effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Weitao, Luo, Peng, Sun, Yueqin, Zhang, Wei, Zhou, Ningning, Zhan, Hongrui, Zhang, Qingxi, Shen, Jie, Lin, Anqi, Cheng, Quan, Wang, Qiongyao, Zhang, Jian, Wang, Hai-Hong, Wei, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194155/
https://www.ncbi.nlm.nih.gov/pubmed/35712081
http://dx.doi.org/10.1016/j.isci.2022.104471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194155/
https://www.ncbi.nlm.nih.gov/pubmed/35712081
http://dx.doi.org/10.1016/j.isci.2022.104471

Ejemplares similares